Now Available: Hungary Pharmaceuticals & Healthcare Report Q3 2014
We expect 2014 to be yet another challenging year for the industry, as a harsh business environment and regulatory burden weigh on market growth. Pricing pressures and slow uptake of new medicines will continue to present near-term headwinds to pharmaceutical sales, as will patent expiries. We anticipate growth will return to the market in 2014 in local currency terms, but this will still represent a decline in real terms.
View full press release